Editors
Christina Fotopoulou
Imperial College London, London, United Kingdom
Christina Fotopoulou is Professor of Gynaecological Cancer Surgery in the Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK and the Deputy Director of the Ovarian Cancer Action Research Centre at Imperial College. She is an Honorary Chair in the Gynaecology Department at the Charité University of Berlin, Germany, where she trained and then later took the role of Vice Director of the Gynaecology Department.
Her surgical and scientific expertise focuses on the management of patients with advanced and relapsed ovarian cancer, profiling of tumour heterogeneity and integration of tumour biology factors with surgical effort under the umbrella of individualisation of surgical care.
Professor Fotopoulou has served as the lead of the Guidelines Committee of the British Gynaecological Cancer Society (BGCS), elected member of the European Society of Gynaecological Oncology (ESGO) council and lead of the ESGO Guidelines Committee and is also a member of the German AGO–Ovarian Cancer Study Group.
She is on the editorial board and reviewer for numerous international gynaecological and oncological journals and is a member of various international oncological committees.
Antonio González-Martín
Clínica Universidad de Navarra, Madrid, Spain
Antonio González-Martín graduated in Medicine from the Universidad de Navarra, Pamplona, Spain and subsequently trained in medical oncology at Hospital Universitario Ramón y Cajal, Madrid, Spain from 1994 to 1997. During 1997, he attended the Mount Sinai School of Medicine in New York, USA as an observer.
Since September 2017 he has been Head of the Medical Oncology Department at Clínica Universidad de Navarra, and in 2020 he was appointed Director of the Cancer Center, Clínica Universidad de Navarra.
Professor González-Martín is an Associate Professor of Medicine at Francisco de Vitoria University, Madrid, Spain and Collaborator Professor at Universidad de Navarra. He obtained his PhD degree at Francisco de Vitoria University in April 2018.
Professor González-Martín is the Chairman of GEICO (Spanish Ovarian Cancer Research Group) and was the President in ENGOT (European Network of Gynaecological Oncological Trials group) for the period 2018–2020. In addition, he is one of the delegates in the Gynecologic Cancer InterGroup (GCIG) and served as Chair of the Ovarian Cancer Committee for the period 2014–2020. He is considered an international expert in gynaecological cancer and has authored several publications and lectured widely on the topic.
Marcia Hall
Brunel University London, London, United Kingdom
Marcia Hall is Professor of Translational Oncology at Brunel University London, London, UK and a Consultant in Medical Oncology at Mount Vernon Cancer Centre, Northwood, UK. She has a background in managing patients with a wide range of cancer types (gastrointestinal, germ cell, breast) but now focuses solely on the treatment of patients with gynaecological cancers.
Professor Hall’s research focus is related to the identification of homologous repair deficiency from circulating (blood samples) factors, and she was the lead for research and development at Mount Vernon Cancer Centre between 2013 and 2021.
Nationally, she has sat on the UK National Cancer Research Institute gynaecological cancers subgroup since 2006 and, internationally, has been a member of the ESMO Educational Publications Working Group (2015–2023; Deputy Chair: 2018–2021).
Authors:
Part A. What every oncologist should know
Chapter 1. Histopathology of gynaecological cancers
- B. Davidson, Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, Oslo; University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, Oslo, Norway
- S. Carinelli, Division of Gynecologic Oncology and Pathology, European Institute of Oncology (IEO), Milan, Italy
Chapter 2. Staging and surgical treatment of ovarian cancer
- S. Mahner, Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University (LMU), Munich, Germany
- G. Aletti, Department of Gynecologic Oncology, European Institute of Oncology (IEO) IRCCS, Milan; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy
Chapter 3. Systemic treatment of ovarian cancer
- M. Hall, Mount Vernon Cancer Centre, Northwood; Brunel University London, London, UK
- A. Berner, Bart’s Cancer Institute, Queen Mary University of London, London, UK
- S. Howlett, Mount Vernon Cancer Centre, Northwood, UK
Chapter 4. Staging and surgical treatment of endometrial cancer
- M.J. Halaska, Department of Gynecology and Obstetrics, Third Medical Faculty, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- L. Rob, Department of Gynecology and Obstetrics, Third Medical Faculty, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
Chapter 5. Non-surgical treatment of endometrial cancer
- A. Leary, Department of Medicine, Gustave Roussy, Villejuif; GynOncTranslational Research Lab, Université Paris-Saclay, Paris, France
- B. Slomovitz, Department of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL; Department of Obstetrics and Gynecology, Florida International University, Miami, FL, USA
Chapter 6. Staging and surgical treatment of cervical cancer
- D. Cibula, Department of Obstetrics and Gynecology, General Teaching Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- L. Dostalek, Department of Obstetrics and Gynecology, General Teaching Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- M. Borcinova, Department of Obstetrics and Gynecology, General Teaching Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
Chapter 7. Non-surgical treatment of cervical cancer
- S. Marnitz, Private Clinic for Radiation Oncology Vosspalais, Berlin, Germany
- C. Fotopoulou, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK
Part B. More advanced knowledge
Chapter 8. Epidemiology and risk factors for ovarian, uterine and cervical cancers
- L. Sánchez-Lorenzo, Medical Oncology Department, Cancer Center, Clínica Universidad de Navarra, Madrid, Spain
- J. Villamayor, Medical Oncology Department, Cancer Center, Clínica Universidad de Navarra, Madrid, Spain
- A. González-Martín, Medical Oncology Department, Cancer Center, Clínica Universidad de Navarra, Madrid, Spain
Chapter 9. Diagnosis and treatment of vulvar cancer
- L. Woelber, Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg; Colposcopy Center, Jerusalem Hospital Hamburg, Hamburg, Germany
- K. Prieske, Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg; Colposcopy Center, Jerusalem Hospital Hamburg, Hamburg; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Chapter 10. Rare gynaecological cancers
- I. Ray-Coquard, Centre Léon Bérard, Lyon, France
- M. Bini, Centre Léon Bérard, Lyon, France; Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy
- S. Quesada, Centre Léon Bérard, Lyon; Institut Régional du Cancer de Montpellier, Montpellier, France
Chapter 11. Hereditary ovarian and uterine cancer syndromes
- V. Wieser, Department of Obstetrics and Gynecology, Medical University, Innsbruck, Austria
- C. Marth, Department of Obstetrics and Gynecology, Medical University, Innsbruck, Austria
Chapter 12. New drugs and novel treatment strategies for gynaecological cancers
- I. Colombo, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland
- C. Sessa, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland
